CA2120234A1 - 2-aminopropan-1,3-diol chemotherapeutic agents - Google Patents

2-aminopropan-1,3-diol chemotherapeutic agents

Info

Publication number
CA2120234A1
CA2120234A1 CA002120234A CA2120234A CA2120234A1 CA 2120234 A1 CA2120234 A1 CA 2120234A1 CA 002120234 A CA002120234 A CA 002120234A CA 2120234 A CA2120234 A CA 2120234A CA 2120234 A1 CA2120234 A1 CA 2120234A1
Authority
CA
Canada
Prior art keywords
agent
tumor
cell
potentiating
growth
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002120234A
Other languages
English (en)
French (fr)
Inventor
Jack B. Jiang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2120234A1 publication Critical patent/CA2120234A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CA002120234A 1991-10-21 1992-10-19 2-aminopropan-1,3-diol chemotherapeutic agents Abandoned CA2120234A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US78073291A 1991-10-21 1991-10-21
US780,732 1991-10-21

Publications (1)

Publication Number Publication Date
CA2120234A1 true CA2120234A1 (en) 1993-04-29

Family

ID=25120504

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002120234A Abandoned CA2120234A1 (en) 1991-10-21 1992-10-19 2-aminopropan-1,3-diol chemotherapeutic agents

Country Status (5)

Country Link
EP (1) EP0609356A4 (xx)
JP (1) JPH07501521A (xx)
AU (1) AU2880192A (xx)
CA (1) CA2120234A1 (xx)
WO (1) WO1993008120A1 (xx)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7030219B2 (en) 2000-04-28 2006-04-18 Johns Hopkins University B7-DC, Dendritic cell co-stimulatory molecules
PE20110435A1 (es) * 2008-08-25 2011-07-20 Amplimmune Inc Composiciones antagonistas del pd-1

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1237670A (en) * 1983-05-26 1988-06-07 Andrew S. Janoff Drug preparations of reduced toxicity
US4816450A (en) * 1986-09-15 1989-03-28 Duke University Inhibition of protein kinase C by long-chain bases

Also Published As

Publication number Publication date
EP0609356A1 (en) 1994-08-10
EP0609356A4 (en) 1994-10-26
AU2880192A (en) 1993-05-21
WO1993008120A1 (en) 1993-04-29
JPH07501521A (ja) 1995-02-16

Similar Documents

Publication Publication Date Title
US11446309B2 (en) Combination therapy for cancer using bromodomain and extra-terminal (BET) protein inhibitors
ES2262626T3 (es) Inhibidores de farnesil proteina transferasa para tratar cancer de mama.
ES2622559T3 (es) Combinación terapéutica que comprende un inhibidor de cdk y un agente antineoplásico
RU2214238C2 (ru) Фармацевтическая композиция, обладающая противоопухолевым действием со сниженными побочными эффектами, содержащая противоопухолевый агент и производное гидроксамовой кислоты
RU2587013C2 (ru) Комбинированная химиотерапия
BRPI0721626A2 (pt) combinaÇço farmacÊutica sinergÍstica para o tratamento de cÂncer
JP2010270124A (ja) 抗癌組み合わせ
JP2002504511A5 (xx)
WO2006039569A1 (en) Combination therapy of hedgehog inhibitors, radiation and chemotherapeutic agents
NZ539514A (en) Combination product of inhibitor of the Src family of non-receptor tyrosine kinases and gemcitabine
JP2009536956A (ja) 抗癌治療法
AU2003225253B2 (en) Drugs for mitigating taxane-induced neurotoxicity
BR112021007283A2 (pt) método de tratamento de um câncer ou câncer refratário
AU2017235346B2 (en) Combination therapy for proliferative diseases
JP3713051B2 (ja) 癌治療の為のＨＭＧ ＣｏＡレダクターゼ阻害剤との組合せに於けるファルネシルトランスフェラーゼ阻害剤
US6355628B1 (en) Combination therapy using pentafluorobenzenesulfonamides
EP2538935B1 (en) Suppression of cancer growth and metastasis using nordihydroguaiaretic acid derivatives with 7-hydroxystaurosporine
RU2657604C2 (ru) Противоопухолевый агент, включающий гидрат гидрохлорида иринотекана
CA2120234A1 (en) 2-aminopropan-1,3-diol chemotherapeutic agents
WO2000056334A1 (en) Use of imino sugars for anti-tumor therapy
WO2020218562A1 (ja) 治療抵抗性がんの予防又は治療用の医薬組成物
RU2763544C2 (ru) Комбинация mcl-1 ингибитора и таксанового соединения, их применения и фармацевтические композиции
EP1651227A1 (en) Combination therapy
RU2314807C2 (ru) Комбинированная противоопухолевая терапия, включающая использование замещенных акрилоилпроизводных дистамицина и лучевой терапии
EP3127544B1 (en) Anti-tumor drug containing anti-tumor platinum complex, and anti-tumor effect enhancer

Legal Events

Date Code Title Description
FZDE Discontinued